FDA Inspection
PPD Development, L.P.PPD Development, L.P. – FDA Inspection, Apr 5, 2023
Record Details
This FDA Inspection record concerns PPD Development, L.P., with an inspection on April 5, 2023, issued by the Minneapolis District Office.
- Company
- PPD Development, L.P.
- Inspection Date
- April 5, 2023
View Company Profile
ID · 61385a36-2db6-4cf0-ad66-26d7e6159aa0
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1202015
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 820.100(a)Lack of or inadequate procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of PPD Development, L.P.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 1, 2026 | Not classified | Minneapolis District Office | |
| September 25, 2025 | VAI | Minneapolis District Office | Drug Quality Assurance |
| July 16, 2021 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 19, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for PPD Development, L.P.
- FDA Inspection 1320960 - 2026-05-01
- FDA Inspection 1284012 - 2025-09-25
- FDA Inspection 1146503 - 2021-07-16
- FDA Inspection 1105196 - 2019-09-19
- FDA Inspection 1056412 - 2018-05-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.